← All studiesType 2 diabetes
Study of a new oral treatment for type 2 diabetes
We are evaluating an investigational oral medication for blood sugar control in adults with type 2 diabetes already taking metformin.
Phase
Phase III
Duration
About 12 months, 8 visits
Location
Hyde Park, MA
Basic eligibility criteria
- Adults 18 to 75 years old
- Type 2 diabetes diagnosed more than 6 months ago
- Currently treated with metformin
The study team will review all criteria with you during your first visit.
What to expect as a participant
- 1
Short initial call to review whether you may qualify
- 2
First site visit: informed consent and screening tests
- 3
Follow-up visits with your medical team
- 4
Final visit and close of participation
Where it takes place
1234 River Street, Hyde Park, MA 02136